IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.1759
-0.0156 (-8.15%)
At close: Mar 16, 2026, 4:00 PM EDT
0.1689
-0.0070 (-3.98%)
After-hours: Mar 16, 2026, 7:58 PM EDT

IO Biotech Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
30.6660.03143.19142.59211.533.41
Cash & Short-Term Investments
30.6660.03143.19142.59211.533.41
Cash Growth
-61.76%-58.08%0.42%-32.59%6112.36%-56.60%
Other Current Assets
6.174.924.065.6310.212.23
Total Current Assets
36.8364.95147.26148.22221.745.64
Net Property, Plant & Equipment
1.852.363.113.230.16-
Other Long-Term Assets
1.280.390.360.350.40.02
Total Assets
39.9667.7150.72151.81222.295.65
Accounts Payable
5.594.663.8843.930.52
Accrued Expenses
11.9414.1111.186.166.382.53
Current Portion of Leases
0.790.720.660.52--
Total Current Liabilities
18.3119.4915.7210.6810.313.05
Long-Term Debt
16.66-----
Long-Term Leases
0.671.21.842.28--
Other Long-Term Liabilities
3.4---0.06-
Total Long-Term Liabilities
20.731.21.842.280.06-
Total Liabilities
39.0520.6817.5612.9510.363.05
Common Stock
0.070.070.070.030.030.03
Additional Paid-in Capital
424.34413.11406.59326.71319.671.11
Accumulated Other Comprehensive Income
---9.67-10.14-1.491.96
Retained Earnings
-416.33-359.31-263.82-177.74-106.28-38.4
Total Common Shareholders' Equity
0.9147.02133.16138.85211.92-35.3
Minority Interest
-----37.91
Shareholders' Equity
0.9147.02133.16138.85211.922.6
Total Liabilities & Equity
39.9667.7150.72151.81222.295.65
Total Debt
18.121.922.492.7900
Net Cash (Debt)
12.5558.12140.7139.8211.533.41
Net Cash Growth
-78.41%-58.70%0.64%-33.91%6112.36%-56.60%
Net Cash Per Share
0.190.883.234.8548.7919.22
Book Value
0.9147.02133.16138.85211.92-35.3
Book Value Per Share
0.010.713.064.8248.88-199.23
Tangible Book Value
0.9147.02133.16138.85211.92-35.3
Tangible Book Value Per Share
0.010.713.064.8248.88-199.23
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q